Alowa, Filma R.
HRN: 21-28-45 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2022
CEFUROXIME 1.5GM (VIAL)
04/25/2022
05/01/2022
IV
1.5g
Q8
Pleural Effusion
Waiting Final Action
05/03/2022
CEFTAZIDIME 1GM (VIAL)
05/03/2022
05/10/2022
IV
1g
Q8
Pleural Effusion
Waiting Final Action